SINGLE-CENTRE/OPEN/RANDOMIZED/PLACEBO-CONTROLLED, 16 WEEKS, PHASE I CLINICAL TRIAL OF ANCILLA DOMINI OB NANO-INVERSE TRANSCRIPTION THERAPEUTICS ON OBESITY DECIMATION/NORMALIZATION

Authors
Category Primary study
Registry of TrialsPan African Clinical Trials Registry
Year 2024
This article has no abstract
Epistemonikos ID: a0b43249f93cc577ea7e77bd77ba298384874f53
First added on: Apr 11, 2025